{
  "ticker": "ALNY",
  "company_name": "Alnylam Pharmaceuticals, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT03672188",
      "title": "Study of VIR-2218 in Healthy Subjects and Patients With Chronic Hepatitis B",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Chronic Hepatitis B",
      "start_date": "2018-11-14",
      "completion_date": "2020-09-03",
      "enrollment": 0,
      "sponsor": "Vir Biotechnology, Inc."
    },
    {
      "nct_id": "NCT04412863",
      "title": "Study of VIR-2218 With or Without Pegylated Interferon Alpha-2a for Treatment of Chronic Hepatitis B Virus Infection",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Chronic Hepatitis B",
      "start_date": "2020-07-03",
      "completion_date": "2024-03-25",
      "enrollment": 0,
      "sponsor": "Vir Biotechnology, Inc."
    },
    {
      "nct_id": "NCT04569903",
      "title": "Evaluation of a Claims-based Algorithm for the Identification of Transthyretin-mediated Amyloidosis (ATTR) Amyloidosis in Medical Records",
      "status": "WITHDRAWN",
      "phase": "EARLY_PHASE1",
      "condition": "Transthyretin Amyloidosis",
      "start_date": "2022-08-01",
      "completion_date": "2025-02-01",
      "enrollment": 0,
      "sponsor": "Yale University"
    },
    {
      "nct_id": "NCT04507269",
      "title": "Study of VIR-2218 in Patients With Chronic Hepatitis B in Mainland China",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Hepatitis B, Chronic",
      "start_date": "2020-08-18",
      "completion_date": "2021-09-30",
      "enrollment": 0,
      "sponsor": "Brii Biosciences Limited"
    }
  ],
  "summary": {
    "total_trials": 4,
    "by_phase": {
      "PHASE1, PHASE2": 1,
      "PHASE2": 2,
      "EARLY_PHASE1": 1
    },
    "by_status": {
      "COMPLETED": 3,
      "WITHDRAWN": 1
    },
    "active_trials": 0,
    "completed_trials": 3,
    "conditions": [
      "Chronic Hepatitis B",
      "Hepatitis B, Chronic",
      "Transthyretin Amyloidosis"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-12T09:33:23.458538",
    "search_query": "Alnylam Pharmaceuticals, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Alnylam+Pharmaceuticals,+Inc."
  }
}